0001104659-21-147286.txt : 20211207 0001104659-21-147286.hdr.sgml : 20211207 20211207172410 ACCESSION NUMBER: 0001104659-21-147286 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20211207 DATE AS OF CHANGE: 20211207 EFFECTIVENESS DATE: 20211207 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Scopus BioPharma Inc. CENTRAL INDEX KEY: 0001772028 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 821248020 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-424033 FILM NUMBER: 211476897 BUSINESS ADDRESS: STREET 1: 420 LEXINGTON AVENUE, SUITE 300 CITY: NEW YORK STATE: NY ZIP: 10170 BUSINESS PHONE: (212) 479-2513 MAIL ADDRESS: STREET 1: 420 LEXINGTON AVENUE, SUITE 300 CITY: NEW YORK STATE: NY ZIP: 10170 FORMER COMPANY: FORMER CONFORMED NAME: Scopus Biopharma Inc. DATE OF NAME CHANGE: 20190327 D 1 primary_doc.xml X0708 D LIVE 0001772028 Scopus BioPharma Inc. 420 LEXINGTON AVE. SUITE 300 NEW YORK NY NEW YORK 10170 212-479-2513 DELAWARE Project18 Inc. Scopus Biopharma Inc. Corporation true 2017 Joshua Lamstein c/o Scopus BioPharma, Inc. 420 Lexington Ave, Suite 300 New York NY NEW YORK 10710 Executive Officer Director Robert J. Gibson c/o Scopus BioPharma, Inc. 420 Lexington Ave, Suite 300 New York NY NEW YORK 10710 Executive Officer Director Ira Scott Greenspan c/o Scopus BioPharma, Inc. 420 Lexington Ave, Suite 300 New York NY NEW YORK 10710 Executive Officer Director David S. Battleman c/o Scopus BioPharma, Inc. 420 Lexington Ave, Suite 300 New York NY NEW YORK 10710 Director David A. Buckel c/o Scopus BioPharma, Inc. 420 Lexington Ave, Suite 300 New York NY NEW YORK 10710 Director Raphael Hofstein c/o Scopus BioPharma, Inc. 420 Lexington Ave, Suite 300 New York NY NEW YORK 10710 Director Paul E. Hopper c/o Scopus BioPharma, Inc. 420 Lexington Ave, Suite 300 New York NY NEW YORK 10710 Director Ashish P. Sanghrajka c/o Scopus BioPharma, Inc. 420 Lexington Ave, Suite 300 New York NY NEW YORK 10710 Director David Weild c/o Scopus BioPharma, Inc. 420 Lexington Ave, Suite 300 New York NY NEW YORK 10710 Director Pharmaceuticals Decline to Disclose 06b false 2021-11-23 false true true true false 0 H.C. Wainwright & Co. LLC 375 None None 430 PARK AVENUE NEW YORK NY NEW YORK 10022 IL ILLINOIS NJ NEW JERSEY NY NEW YORK false 9750000 9750000 0 false 4 828750 0 0 false Scopus BioPharma Inc. /s/ Joshua R. Lamstein Joshua R. Lamstein Chairman 2021-12-07